Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05804188

CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation

Status
Recruiting
Phase
Study type
Observational
Enrollment
105,000 (estimated)
Sponsor
Thomas Riva · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

The investigators' overall objective is to assess the incidence of critical events related to tracheal intubation at all international study sites. Furthermore, the study will investigate the used intubation techniques and identify possible improvement measures to increase patient safety.

Detailed description

It is a prospective observational multi-centre study collecting health related patient data over a period of three months. This serves best the study's purpose to detect the incidence and nature of problems related to tracheal intubation and how such problems are handled with the aim to further improve patient safety. During the observational period the anaesthesia staff in charge will complete a screening questionnaire for critical events associated with tracheal intubation for every patient undergoing general anaesthesia with tracheal intubation. If no critical events arise there are no further requirements. If a critical event occurs, the anaesthesia provider will complete a more detailed questionnaire which includes more questions about what exactly happened. Patient characteristics will be extracted from the anaesthesia records. The investigators will extract such data for all patients undergoing tracheal intubation and additional data for those with critical events. The research will not intervene with the clinical conduct of patient care. The collected health related data will be transferred to an electronic research data base. In this data base data will be encoded. Every patient with a critical event will be followed up as described above.

Conditions

Interventions

TypeNameDescription
OTHERtracheal intubationchildren between 0-16 requiring tracheal intubation

Timeline

Start date
2024-01-08
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2023-04-07
Last updated
2025-05-29

Locations

8 sites across 5 countries: United States, Australia, Canada, Germany, Switzerland

Source: ClinicalTrials.gov record NCT05804188. Inclusion in this directory is not an endorsement.